Revere Partners Announces Investment in FeatherPay

Date:

New York, NY-based oral-health tech investment fund Revere Partners announces investment in FeatherPay to accelerate the consumerization of the patient payment experience in key healthcare segments.

NEW YORK - August 3, 2022 - (Newswire.com)

Revere Partners, the first independent venture fund providing capital for cutting-edge innovations in the oral and systemic health sectors, today announced an investment in FeatherPay, an Atlanta, GA-based healthcare fintech startup. Revere Partners will provide capital, oral-health and related industry expertise, and a vast network of prospective customers and partnerships to support FeatherPay's mission to be healthcare's best payment experience.

"It's unnecessarily difficult for patients to pay healthcare bills, and changing consumer behavior dynamics are compounding the problem of practices getting paid for services. The opportunity to communicate with and accept payments from patients anywhere and on any device is massive. FeatherPay's technology is an elegant, world-class solution to a complex problem across healthcare segments. We are excited to support the mission and vision of these exceptional founders and their incredible team," said Jeremy Krell, MBA, DMD and Managing Director of Revere Partners.

"We are thrilled to welcome Revere Partners to the team. The addition of such a credible and influential force in oral health is both validation of our opportunity and jet fuel for our vision. We are excited to partner with Jeremy and the broader team at Revere Partners in aggressive pursuit of our mission," said Craig Haynor, CEO and co-founder of FeatherPay.

To learn more about FeatherPay and schedule a 15-minute demo, visit www.featherpay.io.

Revere Partners is on a mission to change the landscape of dental and systemic health ventures—to bring market awareness, business acumen, and the top minds in the field together to elevate innovations and optimize both patient and provider experience. A diverse mix of 75 renowned professionals comprises the Revere team—recruited across key areas of dentistry, including DSOs, insurers, manufacturers, distributors, professional associations, academics, labs, retailers and more.  

Press contact [email protected]

FeatherPay is a payment platform that drives revenue and profits, while lowering operational costs for practices, all while delivering a great experience for patients. FeatherPay brings all the different ways a practice enables their patients to pay into a single experience for patients and staff. Patients receive clear simple statements via text, email or paper statement, and can combine multiple payment methods in a single transaction, whether paying in the office, remotely on a mobile device, or even by phone.  FeatherPay also automates and simplifies and digitizes back office operations such as patient billing and AR collections, reconciliation, auditing, refunds, and more, leading to efficient and accurate processes that save time and money.

Press contact [email protected]




Press Release Service by Newswire.com

Original Source: Revere Partners Announces Investment in FeatherPay

Related articles

Judge approves $170M Baby Reindeer lawsuit against Netflix; trial set for May 2025

A judge has ruled that the $170 million lawsuit against Netflix over Baby Reindeer can move forward, with...

Donald Duck Appears on a Custom Episode of Hot Ones as The Walt Disney Company Continues Celebrating 90 Years of the Iconic Duck

Donald Duck is an iconic character and has played a key role in Disney's unparalleled storytelling legacy. Donald's relatable frustrations...

Salem’s Lot (2024) Review: Was this long-delayed Stephen King adaptation worth the wait?

Salem’s Lot (2024) Review: Was this long-delayed Stephen King adaptation worth the wait? Originally published at https://www.joblo.com/salems-lot-2024-review/

Haley Joel Osment remembers Bruce Willis’ leadership on and the twist of The Sixth Sense

On the 25th anniversary of The Sixth Sense, Haley Joel Osment is showing admiration for co-star Bruce Willis. It’s...